Results of a 12-Week Open-Label, Non-Interventional Study of the Efficacy and Safety of Olokizumab Therapy in Patients with Rheumatoid Arthritis after Switching from Anti-B-Cell Therapy during the SARS-CoV-2 Pandemic-Reference-Cited by-同舟云学术

Results of a 12-Week Open-Label, Non-Interventional Study of the Efficacy and Safety of Olokizumab Therapy in Patients with Rheumatoid Arthritis after Switching from Anti-B-Cell Therapy during the SARS-CoV-2 Pandemic

Published:2024-07-01 Issue: Volume: Page:
ISSN:1607-6729
Container-title:Doklady Biochemistry and Biophysics
language:en
Short-container-title:Dokl Biochem Biophys

Author:

Akimova A. A.,Banshchikova N. E.,Sizikov A. E.,Mullagaliev A. A.,Letyagina E. A.,Ilina N. A.,Kurochkina Y. D.,Ubshaeva Y. B.,Omelchenko V. O.,Chumasova O. A.,Shkaruba N. S.,Korolev M. A

Publisher

Pleiades Publishing Ltd

Link

https://link.springer.com/content/pdf/10.1134/S1607672924701060.pdf

Reference28 articles.

1. Belov, B.S. and Leela, A.M., COVID-19 and rheumatology: a year later, Nauchcno-Pract. Revmatol., 2021, vol. 59, no. 1, pp. 31–36. https://doi.org/10.47360/1995-4484-2021-31-36

2. Williamson, E.J., Walker, A.J., Bhaskaran, K., Bacon, S., Bates, Ch., Morton, C.E., Curtis, H.J., Mehrkar, A., Evans, D., Inglesby, P., Cockburn, J., Mcdonald, H.I., Mackenna, B., Tomlinson, L., Douglas, I.J., Rentsch, Ch.T., Mathur, R., Wong, A.Y.S., Grieve, R., Harrison, D., Forbes, H., Schultze, A., Croker, R., Parry, J., Hester, F., Harper, S., Perera, R., Evans, S.J.W., Smeeth, L., and Goldacre, B., Factors associated with COVID-19-related death using OpenSAFELY, Nature, 2020, vol. 584, no. 7821, pp. 430–436. https://doi.org/10.1038/s41586-020-2521-4

3. Liu, M., Gao, Ya., Zhang, Yu., Shi, Sh., Chen, Ya., and Tian, J., The association between severe or dead COVID-19 and autoimmune diseases: A systematic review and meta-analysis, J. Infect., 2020, vol. 81, no. 3, pp. e93–e95. https://doi.org/10.1016/j.jinf.2020.05.065

4. D’Silva, K.M., Serling-Boyd, N., Wallwork, R., Hsu, T., Fu, X., Gravallese, E.M., Choi, H.K., Sparks, J.A., and Wallace, Z.S., Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’, Ann. Rheum. Dis., 2020, vol. 79, no. 9, pp. 1156–1162. https://doi.org/10.1136/annrheumdis-2020-217888

5. Gianfrancesco, M., Hyrich, K.L., Al-Adely, S., et al., Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry, Ann. Rheum. Dis., 2020, vol. 79, no. 7, pp. 859–866. https://doi.org/10.1136/annrheumdis-2020-217871